Add a New Bears Reason
Company: China Medical Technologies (CMED)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
1 votes

  Cant fool all of the people all of the time

Created when NASDAQ:CMED was $15.25 | Edit | History

Market surveys of China IVD market do not confirm CMEDs stated positions in the marketplace in China. Bio-Ekon was acquired for substantial sum but does not really have the product on the market. Is under development and not so competitive with what is out there already. Bio-Ekon is a basically good, small, young company and may turn into something but it is far from how CMED is painting it to the investment community. Real investigative analysts should check into who are the customers of CMED. Perhaps, if they are really generating the revenue they report, the products are going into a warehouse somewhere in China. They are certainly not seen on the street.

(100 character max) Cancel
100%
agree
1 votes

  China Medical Technologies, Inc. Announces Sale Of Its HIFU Business To Chengxuan International Ltd.

Created when NASDAQ:CMED was $18.03 | Edit | History

China Medical Technologies, Inc. announced that the Company has entered into a definitive agreement to sell its High Intensity Focused Ultrasound tumor therapy system business (HIFU Business) to Chengxuan International Ltd. (Chengxuan), its major shareholder for $53.5 million in cash. Chengxuan will make a payment to the Company upon the closing of the sale and two other payments during the year after the closing. Chengxuan is owned by Mr. Xiaodong Wu, the Chairman and Chief Executive Officer of the Company. The transaction is expected to close before the end of December 2008

the news says itself.

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki